{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:25:20Z","timestamp":1792113920462,"version":"4.4.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2042022dx0003"],"award-info":[{"award-number":["2042022dx0003"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2025ZD01999802"],"award-info":[{"award-number":["2025ZD01999802"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Insight"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cellin.2026.100358","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T06:48:51Z","timestamp":1788677331000},"page":"100358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Making Mycobacterium tuberculosis killable: Operational survival phenotyping beyond the persister metaphor"],"prefix":"10.1016","volume":"5","author":[{"given":"Yaqi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5735-8199","authenticated-orcid":false,"given":"Yingying","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellin.2026.100358_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2011.02.022","article-title":"Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism","volume":"145","author":"Adams","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.cellin.2026.100358_bib2","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/infdis\/jiy710","article-title":"Diverse clinical isolates of Mycobacterium tuberculosis develop macrophage-induced rifampin tolerance","volume":"219","author":"Adams","year":"2019","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.cellin.2026.100358_bib3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1216166","article-title":"Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility","volume":"335","author":"Aldridge","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.cellin.2026.100358_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41579-019-0196-3","article-title":"Definitions and guidelines for research on antibiotic persistence","volume":"17","author":"Balaban","year":"2019","journal-title":"Nature Reviews Microbiology"},{"key":"10.1016\/j.cellin.2026.100358_bib5","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1126\/science.1099390","article-title":"Bacterial persistence as a phenotypic switch","volume":"305","author":"Balaban","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.cellin.2026.100358_bib6","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1365-2958.2002.02779.x","article-title":"Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling","volume":"43","author":"Betts","year":"2002","journal-title":"Molecular Microbiology"},{"key":"10.1016\/j.cellin.2026.100358_bib7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(00)74210-3","article-title":"Treatment of staphylococcal infections with penicillin by intermittent sterilisation","volume":"244","author":"Bigger","year":"1944","journal-title":"Lancet"},{"key":"10.1016\/j.cellin.2026.100358_bib8","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1084\/jem.20180518","article-title":"Impact of immunopathology on the antituberculous activity of pyrazinamide","volume":"215","author":"Blanc","year":"2018","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cellin.2026.100358_bib9","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.3389\/fmicb.2020.01924","article-title":"Tolerance and persistence to drugs: A main challenge in the fight against Mycobacterium tuberculosis","volume":"11","author":"Boldrin","year":"2020","journal-title":"Frontiers in Microbiology"},{"key":"10.1016\/j.cellin.2026.100358_bib10","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nrmicro.2016.34","article-title":"Distinguishing between resistance, tolerance and persistence to antibiotic treatment","volume":"14","author":"Brauner","year":"2016","journal-title":"Nature Reviews Microbiology"},{"key":"10.1016\/j.cellin.2026.100358_bib11","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1164\/rccm.201604-0769OC","article-title":"Detection and quantification of differentially culturable tubercle bacteria in sputum from patients with tuberculosis","volume":"194","author":"Chengalroyen","year":"2016","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.cellin.2026.100358_bib12","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1038\/s41564-024-01846-z","article-title":"Single-cell imaging of the Mycobacterium tuberculosis cell cycle reveals linear and heterogenous growth","volume":"9","author":"Chung","year":"2024","journal-title":"Nature Microbiology"},{"key":"10.1016\/j.cellin.2026.100358_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrmicro3200","article-title":"The path of anti-tuberculosis drugs: From blood to lesions to mycobacterial cells","volume":"12","author":"Dartois","year":"2014","journal-title":"Nature Reviews Microbiology"},{"key":"10.1016\/j.cellin.2026.100358_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006077","article-title":"A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen","volume":"4","author":"Deb","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.cellin.2026.100358_bib15","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1164\/rccm.201711-2333OC","article-title":"Drug-penetration gradients associated with acquired drug resistance in patients with tuberculosis","volume":"198","author":"Dheda","year":"2018","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.cellin.2026.100358_bib16","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa2033400","article-title":"Four-month rifapentine regimens with or without moxifloxacin for tuberculosis","volume":"384","author":"Dorman","year":"2021","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.cellin.2026.100358_bib17","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1128\/AAC.00217-12","article-title":"Evaluation of a mouse model of necrotic granuloma formation using C3HeB\/FeJ mice for testing of drugs against Mycobacterium tuberculosis","volume":"56","author":"Driver","year":"2012","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.cellin.2026.100358_bib18","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature13469","article-title":"Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations","volume":"513","author":"Fridman","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2026.100358_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00141-20","article-title":"Mechanisms of drug-induced tolerance in Mycobacterium tuberculosis","volume":"34","author":"Goossens","year":"2020","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1016\/j.cellin.2026.100358_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00570-19","article-title":"Re-growth of Mycobacterium tuberculosis populations exposed to antibiotic combinations is due to the presence of isoniazid and not bacterial growth rate","volume":"63","author":"Hendon-Dunn","year":"2019","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.cellin.2026.100358_bib21","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.20172020","article-title":"Growth of Mycobacterium tuberculosis in vivo segregates with host macrophage metabolism and ontogeny","volume":"215","author":"Huang","year":"2018","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cellin.2026.100358_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1021\/acsinfecdis.5b00127","article-title":"Bedaquiline and pyrazinamide treatment responses are affected by pulmonary lesion heterogeneity in mycobacterium tuberculosis-infected C3HeB\/FeJ mice","volume":"2","author":"Irwin","year":"2016","journal-title":"ACS Infectious Diseases"},{"key":"10.1016\/j.cellin.2026.100358_bib23","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1038\/ncomms4369","article-title":"Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism","volume":"5","author":"Koul","year":"2014","journal-title":"Nature Communications"},{"key":"10.1016\/j.cellin.2026.100358_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2023.102318","article-title":"Adaptation to the intracellular environment of primary human macrophages influences drug susceptibility of Mycobacterium tuberculosis","volume":"139","author":"Lanni","year":"2023","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.cellin.2026.100358_bib25","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1128\/AAC.02637-15","article-title":"Sterilizing activity of pyrazinamide in combination with first-line drugs in a C3HeB\/FeJ mouse model of tuberculosis","volume":"60","author":"Lanoix","year":"2016","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.cellin.2026.100358_bib26","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/AAC.01370-15","article-title":"Selective inactivity of pyrazinamide against tuberculosis in C3HeB\/FeJ mice is best explained by neutral pH of caseum","volume":"60","author":"Lanoix","year":"2016","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.cellin.2026.100358_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2022.100737","article-title":"Design principles to assemble drug combinations for effective tuberculosis therapy using interpretable pairwise drug response measurements","volume":"3","author":"Larkins-Ford","year":"2022","journal-title":"Cell Reports Medicine"},{"key":"10.1016\/j.cellin.2026.100358_bib28","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1128\/JB.00926-09","article-title":"The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancy","volume":"192","author":"Leistikow","year":"2010","journal-title":"Journal of Bacteriology"},{"key":"10.1016\/j.cellin.2026.100358_bib29","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.aaj2191","article-title":"Antibiotic tolerance facilitates the evolution of resistance","volume":"355","author":"Levin-Reisman","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.cellin.2026.100358_bib30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm.3412","article-title":"Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing","volume":"20","author":"Lin","year":"2014","journal-title":"Nature Medicine"},{"key":"10.1016\/j.cellin.2026.100358_bib32","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1126\/science.abq2787","article-title":"Tuberculosis treatment failure associated with evolution of antibiotic resilience","volume":"378","author":"Liu","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.cellin.2026.100358_bib31","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1084\/jem.20151248","article-title":"Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo","volume":"213","author":"Liu","year":"2016","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cellin.2026.100358_bib33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.chom.2014.11.016","article-title":"Stress and host immunity amplify Mycobacterium tuberculosis phenotypic heterogeneity and induce nongrowing metabolically active forms","volume":"17","author":"Manina","year":"2015","journal-title":"Cell Host & Microbe"},{"key":"10.1016\/j.cellin.2026.100358_bib34","doi-asserted-by":"crossref","first-page":"773","DOI":"10.4049\/jimmunol.1300113","article-title":"Microenvironments in tuberculous granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms","volume":"191","author":"Mattila","year":"2013","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cellin.2026.100358_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02192-18","article-title":"Differentially detectable Mycobacterium tuberculosis cells in sputum from treatment-naive subjects in Haiti and their proportionate increase after initiation of treatment","volume":"9","author":"McAulay","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.cellin.2026.100358_bib36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.123.3.445","article-title":"Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues","volume":"123","author":"McCune","year":"1966","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cellin.2026.100358_bib37","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/35021074","article-title":"Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase","volume":"406","author":"McKinney","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2026.100358_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw6635","article-title":"Targeting redox heterogeneity to counteract drug tolerance in replicating Mycobacterium tuberculosis","volume":"11","author":"Mishra","year":"2019","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.cellin.2026.100358_bib39","first-page":"E2874","article-title":"Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance","volume":"112","author":"Moreno-Gamez","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.cellin.2026.100358_bib40","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1164\/rccm.200905-0661OC","article-title":"Resuscitation-promoting factors reveal an occult population of tubercle bacilli in sputum","volume":"181","author":"Mukamolova","year":"2010","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.cellin.2026.100358_bib41","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1038\/ncomms5306","article-title":"Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis","volume":"5","author":"Nandakumar","year":"2014","journal-title":"Nature Communications"},{"key":"10.1016\/j.cellin.2026.100358_bib42","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1038\/s41467-026-72496-4","article-title":"Host oxidative stress primes mycobacteria for rapid antibiotic resistance evolution","volume":"17","author":"Pepper-Tunick","year":"2026","journal-title":"Nature Communications"},{"key":"10.1016\/j.cellin.2026.100358_bib43","doi-asserted-by":"crossref","first-page":"7320","DOI":"10.1128\/AAC.00967-15","article-title":"Uncoupling environmental pH and intrabacterial acidification from pyrazinamide susceptibility in Mycobacterium tuberculosis","volume":"59","author":"Peterson","year":"2015","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.cellin.2026.100358_bib44","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.celrep.2019.12.033","article-title":"Dual RNA-seq of Mtb-infected macrophages in vivo reveals ontologically distinct host-pathogen interactions","volume":"30","author":"Pisu","year":"2020","journal-title":"Cell Reports"},{"key":"10.1016\/j.cellin.2026.100358_bib45","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210615","article-title":"Single cell analysis of M. tuberculosis phenotype and macrophage lineages in the infected lung","volume":"218","author":"Pisu","year":"2021","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cellin.2026.100358_bib46","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1021\/ac1029049","article-title":"High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions","volume":"83","author":"Prideaux","year":"2011","journal-title":"Analytical Chemistry"},{"key":"10.1016\/j.cellin.2026.100358_bib47","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/nm.3937","article-title":"The association between sterilizing activity and drug distribution into tuberculosis lesions","volume":"21","author":"Prideaux","year":"2015","journal-title":"Nature Medicine"},{"key":"10.1016\/j.cellin.2026.100358_bib48","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12879-016-1533-z","article-title":"The effect of growth rate on pyrazinamide activity in Mycobacterium tuberculosis - Insights for early bactericidal activity?","volume":"16","author":"Pullan","year":"2016","journal-title":"BMC Infectious Diseases"},{"key":"10.1016\/j.cellin.2026.100358_bib49","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature22361","article-title":"Deletion of a mycobacterial divisome factor collapses single-cell phenotypic heterogeneity","volume":"546","author":"Rego","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cellin.2026.100358_bib50","doi-asserted-by":"crossref","first-page":"8302","DOI":"10.1073\/pnas.1600372113","article-title":"Temporal and intrinsic factors of rifampicin tolerance in mycobacteria","volume":"113","author":"Richardson","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.cellin.2026.100358_bib51","doi-asserted-by":"crossref","first-page":"19665","DOI":"10.1073\/pnas.1907631116","article-title":"Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance","volume":"116","author":"Safi","year":"2019","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.cellin.2026.100358_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg2612","article-title":"Oxidative damage and delayed replication allow viable Mycobacterium tuberculosis to go undetected","volume":"13","author":"Saito","year":"2021","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.cellin.2026.100358_bib53","first-page":"E4832","article-title":"Rifamycin action on RNA polymerase in antibiotic-tolerant Mycobacterium tuberculosis results in differentially detectable populations","volume":"114","author":"Saito","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.cellin.2026.100358_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00117-22","article-title":"Visualizing pyrazinamide action by live single-cell imaging of phagosome acidification and Mycobacterium tuberculosis pH homeostasis","volume":"13","author":"Santucci","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.cellin.2026.100358_bib55","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1038\/s41467-021-24127-3","article-title":"Intracellular localisation of Mycobacterium tuberculosis affects efficacy of the antibiotic pyrazinamide","volume":"12","author":"Santucci","year":"2021","journal-title":"Nature Communications"},{"key":"10.1016\/j.cellin.2026.100358_bib56","article-title":"An in vitro caseum binding assay that predicts drug penetration in tuberculosis lesions","volume":"123","author":"Sarathy","year":"2017","journal-title":"Journal of Visualized Experiments: JoVE"},{"key":"10.1016\/j.cellin.2026.100358_bib57","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02266-17","article-title":"Extreme drug tolerance of Mycobacterium tuberculosis in caseum","volume":"62","author":"Sarathy","year":"2018","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.cellin.2026.100358_bib58","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1021\/acsinfecdis.6b00051","article-title":"Prediction of drug penetration in tuberculosis lesions","volume":"2","author":"Sarathy","year":"2016","journal-title":"ACS Infectious Diseases"},{"key":"10.1016\/j.cellin.2026.100358_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002773","article-title":"Tuberculosis drugs\u2019 distribution and emergence of resistance in patient\u2019s lung lesions: A mechanistic model and tool for regimen and dose optimization","volume":"16","author":"Strydom","year":"2019","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.cellin.2026.100358_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914942","article-title":"Drug-tolerant Mycobacterium tuberculosis adopt different survival strategies in alveolar macrophages of patients with pulmonary tuberculosis","volume":"24","author":"Ufimtseva","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.cellin.2026.100358_bib61","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01439-20","article-title":"Most-probable-number-based minimum duration of killing assay for determining the spectrum of rifampicin susceptibility in clinical Mycobacterium tuberculosis isolates","volume":"65","author":"Vijay","year":"2021","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.cellin.2026.100358_bib62","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.20030205","article-title":"Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program","volume":"198","author":"Voskuil","year":"2003","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cellin.2026.100358_bib63","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.1229858","article-title":"Dynamic persistence of antibiotic-stressed mycobacteria","volume":"339","author":"Wakamoto","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.cellin.2026.100358_bib64","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00284-23","article-title":"Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responses","volume":"67","author":"Walter","year":"2023","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.cellin.2026.100358_bib65","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1128\/iai.64.6.2062-2069.1996","article-title":"An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence","volume":"64","author":"Wayne","year":"1996","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.cellin.2026.100358_bib66","series-title":"WHO consolidated guidelines on tuberculosis. Module 4: Treatment and care","year":"2025"},{"key":"10.1016\/j.cellin.2026.100358_bib67","doi-asserted-by":"crossref","first-page":"9370","DOI":"10.1038\/s41467-025-64407-w","article-title":"Bioenergetic reprogramming of macrophages reduces drug tolerance in Mycobacterium tuberculosis","volume":"16","author":"Yadav","year":"2025","journal-title":"Nature Communications"},{"key":"10.1016\/j.cellin.2026.100358_bib68","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1128\/AAC.06288-11","article-title":"Targeting persisters for tuberculosis control","volume":"56","author":"Zhang","year":"2012","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.cellin.2026.100358_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2023.102266","article-title":"Spatiotemporal perspectives on tuberculosis chemotherapy","volume":"72","author":"Zhu","year":"2023","journal-title":"Current Opinion in Microbiology"}],"container-title":["Cell Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772892726000611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772892726000611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:28:36Z","timestamp":1790782116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772892726000611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2772892726000611"],"URL":"https:\/\/doi.org\/10.1016\/j.cellin.2026.100358","relation":{},"ISSN":["2772-8927"],"issn-type":[{"value":"2772-8927","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Making Mycobacterium tuberculosis killable: Operational survival phenotyping beyond the persister metaphor","name":"articletitle","label":"Article Title"},{"value":"Cell Insight","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellin.2026.100358","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of Wuhan University.","name":"copyright","label":"Copyright"}],"article-number":"100358"}}